Fibrinogen as a key regulator of inflammation in disease

@article{Davalos2011FibrinogenAA,
  title={Fibrinogen as a key regulator of inflammation in disease},
  author={Dimitrios Davalos and Katerina Akassoglou},
  journal={Seminars in Immunopathology},
  year={2011},
  volume={34},
  pages={43-62}
}
The interaction of coagulation factors with the perivascular environment affects the development of disease in ways that extend beyond their traditional roles in the acute hemostatic cascade. Key molecular players of the coagulation cascade like tissue factor, thrombin, and fibrinogen are epidemiologically and mechanistically linked with diseases with an inflammatory component. Moreover, the identification of novel molecular mechanisms linking coagulation and inflammation has highlighted… 
Fibrinogen: a circulating factor in search of its genetic architecture.
TLDR
The elucidation of the genetic architecture of plasma fibrinogen levels is becoming a major undertaking in translational research and an emerging clinical need.
The Coagulation Factors Fibrinogen, Thrombin, and Factor XII in Inflammatory Disorders—A Systematic Review
TLDR
A number of studies have highlighted coagulation factors to tip the balance between hemostasis and thrombosis and between protection from infection and extensive inflammation, and to optimize the treatment of chronic inflammatory disorders by these factors.
Thrombin, a Mediator of Coagulation, Inflammation, and Neurotoxicity at the Neurovascular Interface: Implications for Alzheimer’s Disease
TLDR
Evidence is presented that thrombin is a convergence point for AD risk factors and as such that thronbin-based therapeutics could target multiple points of AD pathology, including neurodegeneration, vascular activation, and neuroinflammation.
Role of the coagulation system in the pathogenesis of sickle cell disease.
TLDR
Pharmacologic or genetic reduction of circulating prothrombin in Berkeley sickle mice significantly improves survival, ameliorates vascular inflammation, and results in markedly reduced end-organ damage.
Coagulation Pathways in Neurological Diseases: Multiple Sclerosis
TLDR
How hemostasis components are (dys)regulated in MS is discussed, and histopathological post-mortem human brain evidence is summarized, as well as cerebrospinal fluid, plasma, and serum studies of he mostasis and fibrinolytic pathways in MS.
Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics
TLDR
Selective drug targeting to suppress the damaging functions of fibrinogen in the nervous system without affecting its beneficial effects in haemostasis opens a new fibrInogen therapeutics pipeline for neurological disease.
The role of exogenous Fibrinogen in cardiac surgery: stop bleeding or induce cardiovascular disease.
TLDR
The dual role of fibrinogen in cardiac surgeries, bleeding inhibition and CVD is demonstrated and identifying the CVD factors is helpful for designing preventive strategies and alternative drugs.
Thrombin generation and activity in multiple sclerosis.
TLDR
Evidence that thrombin activity directly, through PARs, and indirectly, through fibrin formation and activation of protein C influences neuro-immune responses associated with MS and EAE pathology is summarized.
Inflammation and Acute Phase Proteins in Haemostasis
Inflammation is a very complex reaction to infection or injury the endeavour being to contain the infection and harm to a limited area. The process is associated with the activation of the
Platelets and autoimmunity
TLDR
The current perceptions of platelet involvement in various autoimmune diseases like rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis and multiple sclerosis are discussed.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 231 REFERENCES
Fibrinogen signal transduction as a mediator and therapeutic target in inflammation: lessons from multiple sclerosis.
TLDR
The present article focuses on the recent discoveries of specific cellular targets and receptors for fibrinogen within tissues that have extended the role of fibr inogen from a coagulation factor to a regulator of inflammation and immunity.
Genetic Manipulation of Fibrinogen and Fibrinolysis in Mice
TLDR
A review of the key findings made in recent studies of gene targeted mice with single and combined deficits in fibrinogen and fibrinolytic factors summarizes the role and interplay of these factors in disease progression.
Targeting the coagulation factor fibrinogen for arthritis therapy.
TLDR
Recent studies have demonstrated that eliminating fibrin(ogen)-αMβ2 interactions can significantly limit the progression of multiple inflammatory diseases, including arthritis, without compromising the ability of fibrInogen to function in coagulation.
The role of fibrinogen and fibrinolysis in peripheral arterial disease.
TLDR
The role of fibrinogen in the pathogenesis of PAD and its association with other hemostatic factors is summarized and fibrinolysis in patients with PAD is also considered.
Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways
TLDR
Activation of the coagulation and fibrinolytic cascades in the joint and in the circulation is evident in both inflammatory and degenerative joint diseases.
Overview of hemostatic factors involved in atherosclerotic cardiovascular disease
TLDR
It may be concluded that fibrinogen and CRP determination may be useful screening tools to identify individuals at added risk for thrombotic complications of CVD.
Hemostatic factors and inflammatory disease.
  • J. Degen
  • Medicine
    Thrombosis and haemostasis
  • 1999
TLDR
Despite a myriad of provocative observations made using in vitro systems, there is little direct in vivo evidence supporting an important role of fibrin(ogen) or other hemostatic factors in either the inflammatory response or disease progression.
Role of protease‐activated receptors in inflammatory responses, innate and adaptive immunity
TLDR
The role of PAR activation in the regulation of functional responses of innate and adaptive immune cells in vitro and the mechanisms by which PARs exert the effects of serine proteases on immune cells may lead to new therapeutic strategies in inflammation, immune defense, and allergy are observed.
The missing link between atherosclerosis, inflammation and thrombosis: is it tissue factor?
TLDR
Evidence may also suggest that an increased circulating TF activity may potentiate the initial thrombogenic stimulus represented by vessel wall-associated TF, leading to the formation of larger and/or more stable thrombus, and thus more severe acute coronary syndromes.
Fibrinogen signal transduction in the nervous system
TLDR
Pharmacologic targeting of the interactions of fibrinogen with its nervous system receptors could provide novel strategies for therapeutic intervention in neuroinflammatory and neurodegenerative diseases.
...
1
2
3
4
5
...